BE 
the Cure

BrightEdge exists to accelerate the American Cancer Society’s mission for a world without cancer.

BrightEdge is the American Cancer Society’s donor-funded, philanthropic impact fund. BrightEdge is led by investment fiduciary committee formed of the Society’s leaders and a professional team with expertise in investment and venture capital. BrightEdge operates under a charitable fund model that invests in for-profit companies developing novel cancer-focused therapies and technologies. BrightEdge relies on the expertise of medical and science professionals of the American Cancer Society to evaluate the mission value of investment. BrightEdge’s goal is to accelerate market delivery of today’s promising cancer-related solutions through capital investment, market awareness and a shared commitment to eradicate cancer. BrightEdge is based in Atlanta.
Women in blue in front of blue door

Susan was diagnosed with stage 1a melanoma. Her doctor ordered Castle Biosciences’ DecisionDx-Melanoma test, so she knew her cancer would be aggressive, and a higher risk for metastasis.
She was put on higher intensity surveillance, and when her cancer spread, it was caught early. Six months later, Susan’s scans are clear. BrightEdge invests in companies like Castle Biosciences, because early detection is a key step toward a world without cancer.

BE 
the Cure

BrightEdge exists to accelerate the American Cancer Society’s mission for a world without cancer.

BrightEdge is the American Cancer Society’s donor-funded, philanthropic impact fund. BrightEdge is led by investment fiduciary committee formed of the Society’s leaders and a professional team with expertise in investment and venture capital. BrightEdge operates under a charitable fund model that invests in for-profit companies developing novel cancer-focused therapies and technologies. BrightEdge relies on the expertise of medical and science professionals of the American Cancer Society to evaluate the mission value of investment. BrightEdge’s goal is to accelerate market delivery of today’s promising cancer-related solutions through capital investment, market awareness and a shared commitment to eradicate cancer. BrightEdge is based in Atlanta.

Susan was diagnosed with stage 1a melanoma. Her doctor ordered Castle Biosciences’ DecisionDx-Melanoma test, so she knew her cancer would be aggressive, and a higher risk for metastasis.
She was put on higher intensity surveillance, and when her cancer spread, it was caught early. Six months later, Susan’s scans are clear. BrightEdge invests in companies like Castle Biosciences, because early detection is a key step toward a world without cancer.

Susan was diagnosed with stage 1a melanoma. Her doctor ordered Castle Biosciences’ DecisionDx-Melanoma test, so she knew her cancer would be aggressive, and a higher risk for metastasis.
She was put on higher intensity surveillance, and when her cancer spread, it was caught early. Six months later, Susan’s scans are clear. BrightEdge invests in companies like Castle Biosciences, because early detection is a key step toward a world without cancer.

Cancer

What we’re disrupting
The American Cancer Society has funded over $4.8 billion in research since 1946, resulting in 47 Nobel Laureates, dozens of breakthrough therapies, and thousands of research scholars. While American Cancer Society focuses on tomorrow’s solutions, BrightEdge focuses on accelerating market adoption to innovations today.

Your lifetime risk of being diagnosed with cancer is greater than 1 in 3

1 in 3
607,000+

U.S. cancer-related deaths in 2018

Discover
The American Cancer Society funds over $145 million in basic and translational science each year, advancing the discovery of tomorrow’s solutions for today’s most pressing oncology challenges.
Accelerate
BrightEdge’s goal is to accelerate market delivery of today’s promising cancer-related solutions through capital investment, market awareness and a shared commitment to eradicate cancer

American Cancer Society

A foundation of success
As the largest private, not-for-profit funder of cancer research, the American Cancer Society has played a role in almost all of the cancer research breakthroughs in recent history, while confirming the link between cancer and smoking and the link between obesity and death from breast, colorectal, liver, uterine, and other cancers. The American Cancer Society continues its mission toward a world without cancer.